MEDIKONG
ActiveSummary
The annual accounts of MEDIKONG for financial year 2025 show a net loss of 128% of total assets and of 82% of the equity at the start of that year. The 2025 annual accounts show equity of €19,189 and a net result of -€90,268. Its solvency ranks better than 25% of 20,965 sector peers (NACE 62, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.5% (low).
Group and network
Connections & network
1 connected companyThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
MedSquare
Shared corporate director
→